These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34361071)

  • 21. Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.
    Simmons SJ; Gregg RA; Tran FH; Mo L; von Weltin E; Barker DJ; Gentile TA; Watterson LR; Rawls SM; Muschamp JW
    Addict Biol; 2018 Jan; 23(1):102-110. PubMed ID: 27910188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).
    Sewalia K; Watterson LR; Hryciw A; Belloc A; Ortiz JB; Olive MF
    Neuropharmacology; 2018 May; 134(Pt A):36-45. PubMed ID: 29183686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroadaptive changes and behavioral effects after a sensitization regime of MDPV.
    Duart-Castells L; López-Arnau R; Buenrostro-Jáuregui M; Muñoz-Villegas P; Valverde O; Camarasa J; Pubill D; Escubedo E
    Neuropharmacology; 2019 Jan; 144():271-281. PubMed ID: 30321610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of MDPV-induced place preference in adult Sprague-Dawley rats.
    King HE; Wetzell B; Rice KC; Riley AL
    Drug Alcohol Depend; 2015 Jan; 146():116-9. PubMed ID: 25468817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.
    Collins GT; Sulima A; Rice KC; France CP
    Psychopharmacology (Berl); 2019 Dec; 236(12):3677-3685. PubMed ID: 31346629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between impulsivity and MDPV self-administration in rats.
    Abbott MS; Seaman RW; Doyle MR; Maguire DR; Rice KC; Collins GT
    Addict Biol; 2022 May; 27(3):e13168. PubMed ID: 35470552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice.
    Karlsson L; Andersson M; Kronstrand R; Kugelberg FC
    Basic Clin Pharmacol Toxicol; 2014 Nov; 115(5):411-6. PubMed ID: 24739011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice.
    Calpe-López C; Gasparyan A; Navarrete F; Manzanares J; Miñarro J; Aguilar MA
    J Psychopharmacol; 2021 Jul; 35(7):864-874. PubMed ID: 33427014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic Activity of Pyrovalerone Derivatives, an Emerging Group of Psychostimulant Designer Cathinones.
    Wojcieszak J; Andrzejczak D; Woldan-Tambor A; Zawilska JB
    Neurotox Res; 2016 Aug; 30(2):239-50. PubMed ID: 27295059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabidiol (CBD) reduces cocaine-environment memory in mice.
    Chesworth R; Karl T
    Pharmacol Biochem Behav; 2020 Dec; 199():173065. PubMed ID: 33127382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradoxical anxiolytic effect of the 'bath salt' synthetic cathinone MDPV during early abstinence is inhibited by a chemokine CXCR4 or CCR5 receptor antagonist.
    Simmons SJ; Oliver CF; McCloskey NS; Reitz AB; Nayak SU; Watson MN; Rawls SM
    Drug Alcohol Depend; 2022 Jan; 230():109204. PubMed ID: 34871976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptotic effects of the 'designer drug' methylenedioxypyrovalerone (MDPV) on the neonatal mouse brain.
    Adám A; Gerecsei LI; Lepesi N; Csillag A
    Neurotoxicology; 2014 Sep; 44():231-6. PubMed ID: 25063209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) and structurally related synthetic cathinones.
    Seaman RW; Doyle MR; Sulima A; Rice KC; Collins GT
    Behav Pharmacol; 2021 Aug; 32(5):357-367. PubMed ID: 33587482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells.
    Rosas-Hernandez H; Cuevas E; Lantz SM; Rice KC; Gannon BM; Fantegrossi WE; Gonzalez C; Paule MG; Ali SF
    Neurosci Lett; 2016 Aug; 629():125-130. PubMed ID: 27320055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDPV "high-responder" rats also self-administer more oxycodone than their "low-responder" counterparts under a fixed ratio schedule of reinforcement.
    Gannon BM; Rice KC; Murnane KS
    Psychopharmacology (Berl); 2021 Apr; 238(4):1183-1192. PubMed ID: 33484299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).
    Glennon RA; Young R
    Brain Res Bull; 2016 Sep; 126(Pt 1):111-126. PubMed ID: 27142261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individual Differences in the Relative Reinforcing Effects of 3,4-Methylenedioxypyrovalerone under Fixed and Progressive Ratio Schedules of Reinforcement in Rats.
    Gannon BM; Galindo KI; Rice KC; Collins GT
    J Pharmacol Exp Ther; 2017 Apr; 361(1):181-189. PubMed ID: 28179474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Contingent and Noncontingent Drug Histories on the Development of High Levels of MDPV Self-Administration.
    Doyle MR; Sulima A; Rice KC; Collins GT
    J Pharmacol Exp Ther; 2021 Nov; 379(2):108-116. PubMed ID: 34413199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice.
    Assareh N; Gururajan A; Zhou C; Luo JL; Kevin RC; Arnold JC
    Behav Pharmacol; 2020 Sep; 31(6):591-596. PubMed ID: 32483052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator.
    Gregg RA; Hicks C; Nayak SU; Tallarida CS; Nucero P; Smith GR; Reitz AB; Rawls SM
    Neuropharmacology; 2016 Sep; 108():111-9. PubMed ID: 27085607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.